X-131273813-G-T
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBS1BS2
The NM_001555.5(IGSF1):c.3994C>A(p.Leu1332Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000273 in 1,207,495 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 9 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001555.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IGSF1 | NM_001555.5 | c.3994C>A | p.Leu1332Met | missense_variant | 20/20 | ENST00000361420.8 | NP_001546.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IGSF1 | ENST00000361420.8 | c.3994C>A | p.Leu1332Met | missense_variant | 20/20 | 1 | NM_001555.5 | ENSP00000355010.3 |
Frequencies
GnomAD3 genomes AF: 0.0000179 AC: 2AN: 111656Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33822
GnomAD3 exomes AF: 0.00000553 AC: 1AN: 180918Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 65472
GnomAD4 exome AF: 0.0000283 AC: 31AN: 1095839Hom.: 0 Cov.: 29 AF XY: 0.0000249 AC XY: 9AN XY: 361303
GnomAD4 genome AF: 0.0000179 AC: 2AN: 111656Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33822
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 29, 2024 | The c.4009C>A (p.L1337M) alteration is located in exon 20 (coding exon 19) of the IGSF1 gene. This alteration results from a C to A substitution at nucleotide position 4009, causing the leucine (L) at amino acid position 1337 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at